1 S&P 500 Stock to Own for Decades and 2 to Think Twice About
Even among blue-chip stocks, not all investments are created equal - which is why we built StockStory to help you navigate the market. Keeping that in mind, here is one S&P 500 stock that could deliver good returns and two that could be in trouble.
Market Cap: $959.2 billion
Originally founded by Martin Eberhard and Marc Tarpenning in 2003, Tesla (NASDAQ:TSLA) is an electric vehicle company accelerating the world's transition to sustainable energy.
Why Does TSLA Give Us Pause?
Tesla's scale advantage in EV production leads to gross margins that exceed incumbents such as General Motors and Ford. However, a softer macroeconomic backdrop and tariff pressures have weighed on automobile sales, which are highly cyclical.
The company's execution ability is a question mark given its long history of delays, such as the Cybertruck and Robotaxi launches. Its sizeable investments in projects with uncertain return timelines, like Optimus, also raise skepticism from investors.
On the bright side, Tesla's Megapack product solves a critical problem for utilities needing renewable energy storage solutions. This innovation has made the energy segment the most profitable and fastest-growing business line for the company.
Tesla's stock price of $297.64 implies a valuation ratio of 114.1x forward price-to-earnings. Dive into our free research report to see why there are better opportunities than TSLA.
Market Cap: $84.68 billion
With over 9,000 retail pharmacy locations serving as neighborhood health destinations across America, CVS Health (NYSE:CVS) operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance through its Aetna subsidiary.
Why Are We Wary of CVS?
Sizable revenue base leads to growth challenges as its 7% annual revenue increases over the last two years fell short of other healthcare companies
Estimated sales growth of 2.5% for the next 12 months implies demand will slow from its two-year trend
Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 2.9% annually
CVS Health is trading at $67 per share, or 10.9x forward P/E. To fully understand why you should be careful with CVS, check out our full research report (it's free).
Market Cap: $203.8 billion
Notoriously funded with $7.7 billion from the Softbank Vision Fund, Uber (NYSE:UBER) operates a platform of on-demand services such as ride-hailing, food delivery, and freight.
Why Will UBER Beat the Market?
Monthly Active Platform Consumers have increased by an average of 13.9% annually, giving it the potential for margin-accretive growth if it can develop valuable complementary products and features
Additional sales over the last three years increased its profitability as the 183% annual growth in its earnings per share outpaced its revenue
Free cash flow margin jumped by 17.7 percentage points over the last few years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
At $97.48 per share, Uber trades at 23x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our comprehensive research report, it's free.
The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
15 minutes ago
- Business Insider
Morgan Stanley Sticks to Its Buy Rating for American Homes (AMH)
In a report released yesterday, Adam Kramer from Morgan Stanley maintained a Buy rating on American Homes, with a price target of $41.00. The company's shares closed yesterday at $34.41. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Kramer is an analyst with an average return of -1.4% and a 35.71% success rate. Kramer covers the Real Estate sector, focusing on stocks such as Equity Residential, American Homes, and Equity Lifestyle. In addition to Morgan Stanley, American Homes also received a Buy from BMO Capital's Juan C. Sanabria in a report issued yesterday. However, on August 12, Barclays maintained a Hold rating on American Homes (NYSE: AMH). Based on American Homes' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $459.28 million and a net profit of $109.97 million. In comparison, last year the company earned a revenue of $423.56 million and had a net profit of $112.78 million Based on the recent corporate insider activity of 62 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AMH in relation to earlier this year. Earlier this month, Jay Willoughby, a Director at AMH bought 1,459.00 shares for a total of $49,970.75.
Yahoo
21 minutes ago
- Yahoo
Morgan Stanley Reiterates a Buy Rating on Nu Holdings Ltd. (NU) With an $18 PT
Nu Holdings Ltd. (NYSE:NU) is one of the most buzzing stocks to invest in right now. On August 15, Morgan Stanley analyst Jorge Kuri reiterated a Buy rating on Nu Holdings Ltd. (NYSE:NU) and set a price target of $18.00. A wide angle shot of a team of bankers and financial advisors evaluating an investment portfolio on a touchscreen monitor. The analyst based the rating on Nu Holdings Ltd.'s (NYSE:NU) growth potential and solid performance, stating that it reported notable quarterly results with total revenues and net income surpassing expectations due to strong credit growth. The analyst considers the loan momentum acceleration as a key driver for future earnings upgrades, positioning Nu Holdings Ltd. (NYSE:NU) to continue exhibiting outperformance. Nu Holdings Ltd. (NYSE:NU) is a provider of digital banking services. While we acknowledge the potential of NU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
JPMorgan (JPM) Announces Dividends for Preferred Stock
JPMorgan Chase & Co. (NYSE:JPM) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 15, JPMorgan Chase & Co. (NYSE:JPM) announced dividends on the outstanding shares of its Series II and OO preferred stock. For the Series II preferred stock, JPMorgan Chase & Co. (NYSE:JPM) declared a dividend of $179.80 per preferred share and a dividend of $17.98 per depositary share. pcruciatti / For the Series OO preferred stock, JPMorgan Chase & Co. (NYSE:JPM) announced a dividend of $162.50 per preferred share. The dividend for each depositary share of the Series OO is $16.25. According to the report by JPMorgan Chase & Co. (NYSE:JPM), the dividends will be paid on October 1, 2025, to stockholders of record at the close of business on September 2, 2025. JPMorgan Chase & Co. (NYSE:JPM) is an American multinational financial services firm with leading positions in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. While we acknowledge the potential of JPM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey.